Thomas F. Lüscher - About the Symplicity HTN-3 trial

Thomas F. Lüscher (Switzerland) answers the following questions:

- Can you please tell us more about the design of the SYMPLICITY HTN-3 trial?

- What are your thoughts on the Medtronic press release and how does it affect your daily practice?

- Please can you share your opinion about future indications for renal denervation for the future?